Clinical Trial Update: Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of First Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study [Phase 2]

View source ↗

Summary

A Phase II randomized trial in children with first-relapsed and refractory rhabdomyosarcoma compares Doxorubicin liposome plus Irinotecan (AI regimen) against t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)
• Vincristine (vincristine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Rhabdomyosarcoma, Child | Phase 2 | Status: RECRUITING